Chronic Myeloid Leukemia

  • Bosulif 2015 report

    Bosulif 2015 U.S. PROMOTIONAL AUDIT REPORT Published July 2016 • 25 Pages The 5 Key Questions Addressed by this...

  • Iclusig 2015 report

    Iclusig 2015 U.S. PROMOTIONAL AUDIT REPORT Published July 2016 • 25 Pages The 5 Key Questions Addressed by this...

  • Sprycel 2015 report

    Sprycel 2015 U.S. PROMOTIONAL AUDIT REPORT Published July 2016 • 25 Pages The 5 Key Questions Addressed by this...

  • Synribo 2015 report

    Synribo 2015 U.S. PROMOTIONAL AUDIT REPORT Published July 2016 • 25 Pages The 5 Key Questions Addressed by this...

  • Tasigna 2015 report

    Tasigna 2015 U.S. PROMOTIONAL AUDIT REPORT Published July 2016 • 25 Pages The 5 Key Questions Addressed by this...

  • Bosulif 2014 report

    Bosulif 2014 U.S. PROMOTIONAL AUDIT REPORT Published July 2015 • 22 Pages The 5 Key Questions Addressed by this...

  • Gleevec 2014 report

    Gleevec 2014 U.S. PROMOTIONAL AUDIT REPORT Published July 2015 • 25 Pages The 5 Key Questions Addressed by this...

  • Iclusig 2014 report

    Iclusig 2014 U.S. PROMOTIONAL AUDIT REPORT Published July 2015 • 25 Pages The 5 Key Questions Addressed by this...

  • Sprycel 2014 report

    Sprycel 2014 U.S. PROMOTIONAL AUDIT REPORT Published July 2015 • 26 Pages The 5 Key Questions Addressed by this...

  • Synribo 2014 report

    Synribo 2014 U.S. PROMOTIONAL AUDIT REPORT Published July 2015 • 22 Pages The 5 Key Questions Addressed by this...

  • Tasigna 2014 report

    Tasigna 2014 U.S. PROMOTIONAL AUDIT REPORT Published July 2015 • 25 Pages The 5 Key Questions Addressed by this...